Search Results - "HARPE, Spencer E"

Refine Results
  1. 1

    SGLT2 Inhibitors: A Systematic Review of Diabetic Ketoacidosis and Related Risk Factors in the Primary Literature by Burke, Kelly R., Schumacher, Christine A., Harpe, Spencer E.

    Published in Pharmacotherapy (01-02-2017)
    “…Study Objective Currently only minimal information is available regarding risk factors for the development of sodium glucose cotransporter‐2 inhibitor…”
    Get full text
    Journal Article
  2. 2

    Using Secondary Data Sources for Pharmacoepidemiology and Outcomes Research by Harpe, Spencer E.

    Published in Pharmacotherapy (01-02-2009)
    “…The increased availability of electronic medical records and administrative health care databases is adding to the popularity of pharmacoepidemiology and…”
    Get full text
    Journal Article
  3. 3

    META-INSTI: metabolic adverse events following integrase strand transfer inhibitor administration in spontaneous adverse event reports by Murray, Milena M, Fakhouri, Lara, Harpe, Spencer E

    Published in Drugs in Context (09-08-2023)
    “…Background: Metabolic effects of integrase strand transfer inhibitors (INSTIs) have been reported. The FDA Adverse Event Reporting System (FAERS) is a publicly…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    Meta-research in pharmacy: Time for a look in the mirror by Harpe, Spencer E.

    “…The volume of the biomedical literature continues to expand at a substantial rate. The research literature surrounding pharmaceutical services is no different…”
    Get full text
    Journal Article
  8. 8

    Implementation of an Extended-Infusion Piperacillin-Tazobactam Dosing Protocol: Unexpected Findings when Monitoring Safety and Compliance with Smart Pump Technology by J Rhodes, Nathaniel, Lopez, Jenna, K Pham, Cecilia, Brake, Helga, Fotis, Michael, E Harpe, Spencer, Avedissian, Sean, H Scheetz, Marc

    Published in Pharmacy (11-12-2019)
    “…Compliance with recommended infusion rates was evaluated before, during, and after the implementation of extended-infusion (EI) piperacillin-tazobactam at an…”
    Get full text
    Journal Article
  9. 9

    How to analyze Likert and other rating scale data by Harpe, Spencer E.

    Published in Currents in pharmacy teaching and learning (01-11-2015)
    “…Rating scales and rubrics are commonly used measurement tools in educational contexts. Unfortunately, there is a great deal of controversy surrounding how data…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Out-of-pocket costs and oral cancer medication discontinuation in the elderly by Kaisaeng, Nantana, Harpe, Spencer E, Carroll, Norman V

    “…Cancer is a major cause of mortality and a major contributor to health care costs in the United States. An increasing number of cancer patients are treated…”
    Get full text
    Journal Article
  12. 12

    A Pharmacoepidemiologic Analysis of the Impact of Calendar Packaging on Adherence to Self-Administered Medications for Long-Term Use by Zedler, Barbara K., MD, Joyce, Andrew, PhD, Murrelle, Lenn, MSPH, PhD, Kakad, Priyanka, MS, Harpe, Spencer E., PharmD, PhD, MPH

    Published in Clinical therapeutics (01-05-2011)
    “…Abstract Background Calendar blister packaging (CBP) that incorporates a day or date feature is a simple medication packaging technology that is designed to…”
    Get full text
    Journal Article
  13. 13

    Pseudomonas aeruginosa, Staphylococcus aureus, and fluoroquinolone use by MacDougall, Conan, Harpe, Spencer E, Powell, J Patrick, Johnson, Christopher K, Edmond, Michael B, Polk, Ron E

    Published in Emerging infectious diseases (01-08-2005)
    “…Few long-term multicenter investigations have evaluated the relationships between aggregate antimicrobial drug use in hospitals and bacterial resistance. We…”
    Get full text
    Journal Article
  14. 14

    Characteristics of studies of pharmacist services registered in ClinicalTrials.gov by Dammo, Nahreen, Harpe, Spencer E.

    “…To examine the characteristics of studies of pharmacist services registered in ClinicalTrials.gov. Cross-sectional study. ClinicalTrials.gov and MEDLINE…”
    Get full text
    Journal Article
  15. 15

    Warfarin-antibiotic interactions in older adults of an outpatient anticoagulation clinic by Ghaswalla, Parinaz K, Harpe, Spencer E, Tassone, Daniel, Slattum, Patricia W

    “…Several classes of drugs, such as antibiotics, may interact with warfarin to cause an increase in warfarins anticoagulant activity and the clinical relevance…”
    Get more information
    Journal Article
  16. 16

    Increase in Use of Vancomycin for Clostridium difficile Infection in US Hospitals by Pakyz, Amy L., Carroll, Norman V., Harpe, Spencer E., Oinonen, Michael, Polk, Ronald E.

    “…Clostridium difficile infection (CDI) is a potentially serious disease for which the epidemiology has recently changed, because of an emerging drug-resistant…”
    Get full text
    Journal Article
  17. 17

    Updating conceptions of validity and reliability by Peeters, Michael J., Harpe, Spencer E.

    “…Measurement validity is important when conducting research. This is as true for sociobehavioral research as for clinical research. Although the importance of…”
    Get full text
    Journal Article
  18. 18

    Warfarin use in nursing home residents: results from the 2004 national nursing home survey by Ghaswalla, Parinaz K, Harpe, Spencer E, Slattum, Patricia W

    “…Practice guidelines recommend anticoagulation therapy with warfarin for stroke prevention in patients with atrial fibrillation (AF). Despite this, warfarin is…”
    Get more information
    Journal Article
  19. 19

    Patient preferences for objective quality metrics during community pharmacy selection: A discrete choice experiment by Patterson, Julie A., Holdford, David A., Harpe, Spencer E.

    “…Patients select healthcare providers and facilities based on a complex array of factors. Pharmacy-level quality metrics have been discussed as a way to help…”
    Get full text
    Journal Article
  20. 20

    Medication risk factors associated with healthcare-associated Clostridium difficile infection: a multilevel model case–control study among 64 US academic medical centres by Pakyz, Amy L., Jawahar, Rachel, Wang, Qin, Harpe, Spencer E.

    Published in Journal of antimicrobial chemotherapy (01-04-2014)
    “…Objectives The main objective of this study was to determine patient- and hospital-level medication risk factors associated with Clostridium difficile…”
    Get full text
    Journal Article